These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33044319)

  • 21. Effective control of SARS-CoV-2 transmission in Wanzhou, China.
    Shi Q; Hu Y; Peng B; Tang XJ; Wang W; Su K; Luo C; Wu B; Zhang F; Zhang Y; Anderson B; Zhong XN; Qiu JF; Yang CY; Huang AL
    Nat Med; 2021 Jan; 27(1):86-93. PubMed ID: 33257893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of contact tracing and quarantine on reducing COVID-19 transmission: a retrospective cohort study.
    Malheiro R; Figueiredo AL; Magalhães JP; Teixeira P; Moita I; Moutinho MC; Mansilha RB; Gonçalves LM; Ferreira E
    Public Health; 2020 Dec; 189():54-59. PubMed ID: 33160088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel.
    Dickens BL; Koo JR; Lim JT; Sun H; Clapham HE; Wilder-Smith A; Cook AR
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 32841354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of the COVID-19 in Iraq - Implications for travellers.
    Al-Malkey MK; Al-Sammak MA
    Travel Med Infect Dis; 2020; 38():101739. PubMed ID: 32405265
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of Contact Tracing for Viral Disease Mitigation and Suppression: Evidence-Based Review.
    Thomas Craig KJ; Rizvi R; Willis VC; Kassler WJ; Jackson GP
    JMIR Public Health Surveill; 2021 Oct; 7(10):e32468. PubMed ID: 34612841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the COVID-19 risk during the Hajj pilgrimage.
    Khan A; Bieh KL; El-Ganainy A; Ghallab S; Assiri A; Jokhdar H
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 32889536
    [No Abstract]   [Full Text] [Related]  

  • 27. Estimating in real time the efficacy of measures to control emerging communicable diseases.
    Cauchemez S; Boëlle PY; Thomas G; Valleron AJ
    Am J Epidemiol; 2006 Sep; 164(6):591-7. PubMed ID: 16887892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcritical Transmission in the Early Stage of COVID-19 in Korea.
    Won YS; Kim JH; Ahn CY; Lee H
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33572542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial Coronavirus Disease Outbreak Containment, Hanoi, Vietnam, March-April 2020.
    Duy C; Nong VM; Van Ngo A; Doan TT; Nguyen TQ; Truong PT; Olson L; Larsson M
    Emerg Infect Dis; 2021 Jan; 27(1):10-7. PubMed ID: 33207153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries.
    Han X; Xu Y; Fan L; Huang Y; Xu M; Gao S
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34285082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological Investigation of the First 135 COVID-19 Cases in Brunei: Implications for Surveillance, Control, and Travel Restrictions.
    Wong J; Chaw L; Koh WC; Alikhan MF; Jamaludin SA; Poh WWP; Naing L
    Am J Trop Med Hyg; 2020 Oct; 103(4):1608-1613. PubMed ID: 32815514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore.
    Lee VJ; Chiew CJ; Khong WX
    J Travel Med; 2020 May; 27(3):. PubMed ID: 32167146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nine-month Trend of Time-Varying Reproduction Numbers of COVID-19 in West of Iran.
    Rahimi E; Hashemi Nazari SS; Mokhayeri Y; Sharhani A; Mohammadi R
    J Res Health Sci; 2021 Jun; 21(2):e00517. PubMed ID: 34465640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating effects of intervention measures on COVID-19 outbreak in Wuhan taking account of improving diagnostic capabilities using a modelling approach.
    Liang J; Yuan HY; Wu L; Pfeiffer DU
    BMC Infect Dis; 2021 May; 21(1):424. PubMed ID: 33952194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission.
    Lokuge K; Banks E; Davis S; Roberts L; Street T; O'Donovan D; Caleo G; Glass K
    BMC Med; 2021 Feb; 19(1):50. PubMed ID: 33596902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of COVID-19 in Australia through quarantine: the role of special health accommodation (SHA) in New South Wales, Australia.
    Fotheringham P; Anderson T; Shaw M; Jewitt J; Storey H; Hutchings O; Cartwright J; Gupta L
    BMC Public Health; 2021 Jan; 21(1):225. PubMed ID: 33504347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 control in Vietnam.
    Van Tan L
    Nat Immunol; 2021 Mar; 22(3):261. PubMed ID: 33627879
    [No Abstract]   [Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the effect of selective border relaxation on COVID-19 in New Zealand.
    Smith BJ; Morris AJ; Johnston B; Child S; Thornley S
    N Z Med J; 2021 Feb; 134(1529):10-25. PubMed ID: 33582704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.